David Shaw’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,617
Closed -$397K 4850
2023
Q4
$308K Sell
1,617
-2,883
-64% -$545K ﹤0.01% 3741
2023
Q3
$896K Sell
4,500
-106,245
-96% -$25.1M ﹤0.01% 3128
2023
Q2
$31.6M Buy
110,745
+60,846
+122% +$16.9M 0.03% 619
2023
Q1
$10.8M Sell
49,899
-63,841
-56% -$12.4M 0.01% 1298
2022
Q4
$23.4M Buy
113,740
+25,335
+29% +$6.41M 0.03% 828
2022
Q3
$24.6M Buy
+88,405
New +$22.5M 0.03% 733
2022
Q2
Sell
-39,242
Closed -$8.14M 5902
2022
Q1
$8.14M Sell
39,242
-63,050
-62% -$10.4M 0.01% 1801
2021
Q4
$18.2M Sell
102,292
-51,799
-34% -$10.2M 0.02% 1148
2021
Q3
$31.7M Sell
154,091
-50,498
-25% -$9.91M 0.03% 757
2021
Q2
$38.8M Sell
204,589
-1,288
-0.6% -$211K 0.03% 669
2021
Q1
$26.8M Sell
205,877
-61,678
-23% -$7.4M 0.03% 775
2020
Q4
$27.8M Sell
267,555
-11,380
-4% -$986K 0.02% 793
2020
Q3
$21.1M Buy
278,935
+238,050
+582% +$13.5M 0.02% 800
2020
Q2
$1.94M Buy
+40,885
New +$1.68M ﹤0.01% 2432

Other funds holding SWAV

David Shaw's SWAV Position: Q1 2024 in Review

David Shaw sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,617 shares — an estimated $397K sold.

David Shaw first reported a position in SWAV in Q2 2020 and held it in 14 quarters. The position peaked at $38.8M in Q2 2021. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • David Shaw reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 1,617 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $397K.
  • David Shaw first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • David Shaw's Shockwave Medical, Inc. Common Stock position peaked at $38.8M in Q2 2021.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.